This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raff, H. Articles by Findling, J. W. Search for Related Content PubMed PubMed Citation Articles by Raff, H. Articles by Findling, J. W.

Late-Night Salivary Cortisol as a Screening Test for Cushing’s Syndrome¹

Endocrine Research Laboratory and the Endocrine-Diabetes Center, St. Luke’s Medical Center, Medical College of Wisconsin, Milwaukee, Wisconsin 53215

Address all correspondence and requests for reprints to: Hershel Raff, Ph.D., St. Luke’s Health Science Center, 2901 West KK River Parkway, Suite 503, Milwaukee, Wisconsin 53215. E-mail: hraff{at}post.its.mcw.edu

The clinical features of Cushing’s syndrome (such as obesity, hypertension, and diabetes) are commonly encountered in clinical practice. Patients with Cushing’s syndrome have been identified by an abnormal low-dose dexamethasone suppression test, elevated urine free cortisol (UFC), an absence of diurnal rhythm of plasma cortisol, or an elevated late-night plasma cortisol. Because the concentration of cortisol in the saliva is in equilibrium with the free (active) cortisol in the plasma, measurement of salivary cortisol in the evening (nadir) and morning (peak) may be a simple and convenient screening test for Cushing’s syndrome. The purpose of this study was to evaluate the usefulness of the measurement of late-night and morning salivary cortisol in the diagnosis of Cushing’s syndrome.

We studied 73 normal subjects and 78 patients referred for the diagnosis of Cushing’s syndrome. Salivary cortisol was measured at 2300 h and 0700 h using a simple, commercially-available saliva collection device and a modification of a standard cortisol RIA. In addition, 24-h UFC was measured within 1 month of saliva sampling.

Patients with proven Cushing’s syndrome (N = 39) had significantly elevated 2300-h salivary cortisol (24.0 ± 4.5 nmol/L), as compared with normal subjects (1.2 ± 0.1 nmol/L) or with patients referred with the clinical features of hypercortisolism in whom the diagnosis was excluded or not firmly established (1.6 ± 0.2 nmol/L; N = 39). Three of 39 patients with proven Cushing’s had 2300-h salivary cortisol less than the calculated upper limit of the reference range (3.6 nmol/L), yielding a sensitivity of 92%; one of these 3 patients had intermittent hypercortisolism, and one had an abnormal diurnal rhythm (salivary cortisol 0700-h to 2300-h ratio <2). An elevated 2300-h salivary cortisol and/or an elevated UFC identified all 39 patients with proven Cushing’s syndrome (100% sensitivity). Salivary cortisol measured at 0700 h demonstrated significant overlap between groups, even though it was significantly elevated in patients with proven Cushing’s syndrome (23.0 ± 4.2 nmol/L), as compared with normal subjects (14.5 ± 0.8 nmol/L) or with patients in whom Cushing’s was excluded or not firmly established (15.3 ± 1.5 nmol/L).

Late-night salivary cortisol measurement is a simple and reliable screening test for spontaneous Cushing’s syndrome. In addition, late-night salivary cortisol measurements may simplify the evaluation of suspected intermittent hypercortisolism, and they may facilitate the screening of large high-risk populations (e.g. patients with diabetes mellitus).

This article has been cited by other articles:

				L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540. [Abstract] [Full Text] [PDF]

				M. B. Elamin, M. H. Murad, R. Mullan, D. Erickson, K. Harris, S. Nadeem, R. Ennis, P. J. Erwin, and V. M. Montori Accuracy of Diagnostic Tests for Cushing's Syndrome: A Systematic Review and Metaanalyses J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1553 - 1562. [Abstract] [Full Text] [PDF]

				S. Kidambi, H. Raff, and J. W Findling Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome Eur. J. Endocrinol., December 1, 2007; 157(6): 725 - 731. [Abstract] [Full Text] [PDF]

				S. K. Baid, N. Sinaii, M. Wade, D. Rubino, and L. K. Nieman Radioimmunoassay and Tandem Mass Spectrometry Measurement of Bedtime Salivary Cortisol Levels: A Comparison of Assays to Establish Hypercortisolism J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3102 - 3107. [Abstract] [Full Text] [PDF]

				A. M Maguire, G. R Ambler, B. Moore, K. Waite, M. McLean, and C. T Cowell The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism Eur. J. Endocrinol., April 1, 2007; 156(4): 471 - 476. [Abstract] [Full Text] [PDF]

				S. H. Golden, S. Malhotra, G. S. Wand, F. L. Brancati, D. Ford, and K. Horton Adrenal Gland Volume and Dexamethasone-Suppressed Cortisol Correlate with Total Daily Salivary Cortisol in African-American Women J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1358 - 1363. [Abstract] [Full Text] [PDF]

				S. Kidambi, J. M. Kotchen, C. E. Grim, H. Raff, J. Mao, R. J. Singh, and T. A. Kotchen Association of Adrenal Steroids With Hypertension and the Metabolic Syndrome in Blacks Hypertension, March 1, 2007; 49(3): 704 - 711. [Abstract] [Full Text] [PDF]

				A. Klibanski, A. E. Stephen, M. F. Greene, M. A. Blake, and C.-L. Wu Case 36-2006 -- A 35-Year-Old Pregnant Woman with New Hypertension. N. Engl. J. Med., November 23, 2006; 355(21): 2237 - 2245. [Full Text] [PDF]

				J. W. Findling and H. Raff Cushing's Syndrome: Important Issues in Diagnosis and Management J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3746 - 3753. [Abstract] [Full Text] [PDF]

				S. PETERSENN, N. UNGER, M. K WALZ, and K. MANN Diagnostic value of biochemical parameters in the differential diagnosis of an adrenal mass. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 348 - 357. [Abstract] [Full Text] [PDF]

				G. Reimondo, B. Allasino, S. Bovio, P. Paccotti, A. Angeli, and M. Terzolo Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome Eur. J. Endocrinol., December 1, 2005; 153(6): 803 - 809. [Abstract] [Full Text] [PDF]

				R. S. Chriguer, L. L. K. Elias, I. M. da Silva Jr., J. G. H. Vieira, A. C. Moreira, and M. de Castro Glucocorticoid Sensitivity in Young Healthy Individuals: in Vitro and in Vivo Studies J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5978 - 5984. [Abstract] [Full Text] [PDF]

				A. Viardot, P. Huber, J. J. Puder, H. Zulewski, U. Keller, and B. Muller Reproducibility of Nighttime Salivary Cortisol and Its Use in the Diagnosis of Hypercortisolism Compared with Urinary Free Cortisol and Overnight Dexamethasone Suppression Test J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5730 - 5736. [Abstract] [Full Text] [PDF]

				M. Terzolo, S. Bovio, A. Pia, P. A. Conton, G. Reimondo, C. Dall'Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma Eur. J. Endocrinol., August 1, 2005; 153(2): 307 - 315. [Abstract] [Full Text] [PDF]

				M. Yaneva, H. Mosnier-Pudar, M.-A. Dugue, S. Grabar, Y. Fulla, and X. Bertagna Midnight Salivary Cortisol for the Initial Diagnosis of Cushing's Syndrome of Various Causes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3345 - 3351. [Abstract] [Full Text] [PDF]

				G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]

				J. W. Findling, H. Raff, and D. C. Aron The Low-Dose Dexamethasone Suppression Test: A Reevaluation in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1222 - 1226. [Abstract] [Full Text] [PDF]

				G. Arnaldi, A. Angeli, A. B. Atkinson, X. Bertagna, F. Cavagnini, G. P. Chrousos, G. A. Fava, J. W. Findling, R. C. Gaillard, A. B. Grossman, et al. Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5593 - 5602. [Abstract] [Full Text] [PDF]

				P. Putignano, P. Toja, A. Dubini, F. P. Giraldi, S. M. Corsello, and F. Cavagnini Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol as Screening Tests for Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4153 - 4157. [Abstract] [Full Text] [PDF]

				H. Raff and J. W. Findling A Physiologic Approach to Diagnosis of the Cushing Syndrome Ann Intern Med, June 17, 2003; 138(12): 980 - 991. [Full Text] [PDF]

				H. Raff, P. J. Homar, and D. P. Skoner New Enzyme Immunoassay for Salivary Cortisol Clin. Chem., January 1, 2003; 49(1): 203 - 204. [Full Text] [PDF]

				D. A. Papanicolaou, N. Mullen, I. Kyrou, and L. K. Nieman Nighttime Salivary Cortisol: A Useful Test for the Diagnosis of Cushing's Syndrome J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4515 - 4521. [Abstract] [Full Text] [PDF]

				L. K. NIEMAN Diagnostic Tests for Cushing's Syndrome Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 112 - 118. [Abstract] [Full Text] [PDF]

				H. Raff, P. J. Homar, and E. A. Burns Comparison of Two Methods for Measuring Salivary Cortisol Clin. Chem., January 1, 2002; 48(1): 207 - 208. [Full Text] [PDF]

				J. Hjertstedt, E. A. Burns, R. Fleming, H. Raff, I. Rudman, E. H. Duthie, and C. R. Wilson Mandibular and Palatal Tori, Bone Mineral Density, and Salivary Cortisol in Community-Dwelling Elderly Men and Women J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2001; 56(11): M731 - 735. [Abstract] [Full Text] [PDF]

				M. Moro, P. Putignano, M. Losa, C. Invitti, C. Maraschini, and F. Cavagnini The Desmopressin Test in the Differential Diagnosis between Cushing's Disease and Pseudo-Cushing States J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3569 - 3574. [Abstract] [Full Text]

				M. Castro, P. C. L. Elias, A. R. P. Quidute, F. P. B. Halah, and A. C. Moreira Out-Patient Screening for Cushing's Syndrome: The Sensitivity of the Combination of Circadian Rhythm and Overnight Dexamethasone Suppression Salivary Cortisol Tests J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 878 - 882. [Abstract] [Full Text]